Katamnesis regarding symptom development and health care utilization after in-Patient psychosomatic-psychotherapeutic treatment

Not yet recruiting

• Conditions: F32; F33; F34; F40; F41; F42; F43; F44; F45; F48

• Registration Number: DRKS00013202
• Lead Sponsor: Klinik für Psychosomatik und PsychotherapieUKM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-10-23
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

all former in-patients of our department who were treated starting with August 2016 and agreed to katamnesis

Exclusion Criteria

none

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptom and resources development is measured 1 year after the inpatient treatment and then yearly by means of standardized questionnaires, which the patients also completed during inpatient treatment: Patient Health Questionnaire (PHQ), Eating Disorder Examination Questionnaire (EDE-Q), Pain Disability Index (PDI), Posttraumatic Diagnostic Scale (PDS), Resiliency Scale (RS-13), Sense of Coherence Scale (SOC-13), OPD-Structure-Questionnaire (OPD-SF12).

Secondary Outcome Measures

Name	Time	Method
The subjective assessment of the treatment success and utilization of medical Services is measured one year after the inpatient treatment and then yearly by means of a questionnaire.